Safety and Survival Outcomes of177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior223Ra treatment: The RALU Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.